Skip to main content

Beam Therapeutics Inc 10-Q for FY2026 Q1

Beam Therapeutics Inc. (BEAM)

10-Q 2026-05-07 For: 2026-03-31
View Original
Added on May 07, 2026

About this 10-Q

Beam Therapeutics Inc filed this 10-Q on May 7, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$31.74M
up 324.9% from $7.47M a year earlier
Net loss
$94.32M
compared with a net loss of $108.33M a year earlier
Diluted EPS
-$0.91
compared with -$1.23 a year earlier